← FDA Drug Approvals (Drugs@FDA)

SUCRALFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2024-07-23

Drug application

FDA Application #

ANDA212769

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUCRALFATE

Generic name

Sucralfate

Active ingredients

SUCRALFATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

HIKMA

First approval

2024-07-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown